Jane Street Group, LLC Annexon, Inc. Transaction History
Jane Street Group, LLC
- $88.2 Billion
- Q2 2024
A detailed history of Jane Street Group, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 69,965 shares of ANNX stock, worth $491,853. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,965
Previous 132,425
47.17%
Holding current value
$491,853
Previous $949,000
63.96%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
101MCall Options Held
3.73MPut Options Held
1.3M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$59.4 Million8.47% of portfolio
-
Satter Management Co., L.P.7.41MShares$52.1 Million71.21% of portfolio
-
Bvf Inc San Francisco, CA7MShares$49.2 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$46.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$45.2 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $335M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...